Surgery Partners, Inc. (NASDAQ:SGRY - Get Free Report) CFO David T. Doherty sold 6,733 shares of Surgery Partners stock in a transaction dated Monday, March 10th. The shares were sold at an average price of $24.02, for a total transaction of $161,726.66. Following the transaction, the chief financial officer now directly owns 150,868 shares of the company's stock, valued at approximately $3,623,849.36. This trade represents a 4.27 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink.
Surgery Partners Stock Performance
SGRY traded up $0.21 during midday trading on Thursday, reaching $23.61. The company had a trading volume of 819,582 shares, compared to its average volume of 1,067,027. Surgery Partners, Inc. has a 1 year low of $19.50 and a 1 year high of $33.97. The company has a quick ratio of 1.66, a current ratio of 1.80 and a debt-to-equity ratio of 0.99. The company has a market cap of $3.01 billion, a P/E ratio of -49.19, a P/E/G ratio of 19.21 and a beta of 2.73. The business has a 50-day moving average of $23.48 and a two-hundred day moving average of $26.16.
Surgery Partners (NASDAQ:SGRY - Get Free Report) last announced its quarterly earnings data on Monday, March 3rd. The company reported $0.39 EPS for the quarter, beating the consensus estimate of $0.38 by $0.01. The firm had revenue of $864.40 million for the quarter, compared to the consensus estimate of $828.09 million. Surgery Partners had a negative net margin of 2.03% and a positive return on equity of 2.85%. As a group, equities research analysts predict that Surgery Partners, Inc. will post 0.67 earnings per share for the current fiscal year.
Analysts Set New Price Targets
Several research firms recently weighed in on SGRY. Royal Bank of Canada cut their price target on Surgery Partners from $49.00 to $35.00 and set an "outperform" rating on the stock in a research note on Wednesday, November 20th. Bank of America assumed coverage on shares of Surgery Partners in a report on Monday, December 16th. They issued a "buy" rating and a $30.00 target price for the company. Macquarie decreased their price objective on shares of Surgery Partners from $34.00 to $33.00 and set an "outperform" rating for the company in a report on Tuesday. Finally, JPMorgan Chase & Co. reduced their target price on Surgery Partners from $38.00 to $28.00 and set a "neutral" rating for the company in a report on Tuesday, December 3rd. One investment analyst has rated the stock with a sell rating, two have issued a hold rating and seven have assigned a buy rating to the company's stock. According to MarketBeat, the company has a consensus rating of "Moderate Buy" and a consensus target price of $36.63.
Read Our Latest Research Report on Surgery Partners
Hedge Funds Weigh In On Surgery Partners
Several large investors have recently made changes to their positions in the business. KBC Group NV raised its stake in Surgery Partners by 31.8% during the 3rd quarter. KBC Group NV now owns 2,385 shares of the company's stock valued at $77,000 after purchasing an additional 576 shares during the period. State of Wyoming grew its holdings in Surgery Partners by 94.4% during the 4th quarter. State of Wyoming now owns 4,002 shares of the company's stock valued at $85,000 after buying an additional 1,943 shares in the last quarter. Point72 Asia Singapore Pte. Ltd. raised its position in shares of Surgery Partners by 12.1% during the fourth quarter. Point72 Asia Singapore Pte. Ltd. now owns 4,296 shares of the company's stock valued at $91,000 after buying an additional 465 shares during the last quarter. MeadowBrook Investment Advisors LLC boosted its position in shares of Surgery Partners by 16.6% during the fourth quarter. MeadowBrook Investment Advisors LLC now owns 10,280 shares of the company's stock worth $218,000 after acquiring an additional 1,460 shares during the last quarter. Finally, Tower Research Capital LLC TRC grew its stake in Surgery Partners by 279.3% during the fourth quarter. Tower Research Capital LLC TRC now owns 10,762 shares of the company's stock valued at $228,000 after acquiring an additional 7,925 shares in the last quarter.
About Surgery Partners
(
Get Free Report)
Surgery Partners, Inc, together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.
Featured Articles
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Surgery Partners, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Surgery Partners wasn't on the list.
While Surgery Partners currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
